Brief: Vicore And Nippon Shinyaku Enter Into An Exclusive License Agreement

Vicore Pharma Holding AB

09/02/2024 07:20

Feb 9 (Reuters) - Vicore Pharma Holding AB (publ)
 VICOR.ST :
    * VICORE AND NIPPON SHINYAKU ENTER INTO AN EXCLUSIVE LICENSE
AGREEMENT TO DEVELOP AND COMMERCIALIZE C21 IN JAPAN
    * UNDER TERMS OF AGREEMENT, VICORE WILL RECEIVE AN UPFRONT
PAYMENT
OF USD 10 MILLION AND IS ENTITLED TO POTENTIAL DEVELOPMENT AND
COMMERCIAL MILESTONE PAYMENTS UP TO A TOTAL OF USD 275 MILLION

Source text for Eikon:  ID:nMFN20cCcw 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))